Authorization: If suitable, we prescribe the appropriate dosage of FDA approved GLP-1 or GIP to support your weight loss journey
For treatment through the NHS, patients are typically required to have: A Body Mass Index (BMI) of 40 or above At least four of the following weight-related conditions High blood pressure (hypertension) Heart disease (cardiovascular disease) Abnormal blood fats (dyslipidemia) Obstructive sleep apnea Type 2 diabetes Must have tried other weight loss methods first Women make up the majority of Mounjaro users in the UK at more than three-quarters (77.6%), while men account for 22.4% of users
The switching from tirzepatide to retatrutide guide covers the newer option
Label Ingredients: bulking agent (methyl cellulose), reduced L-glutathione, anti-caking agent (vegetable magnesium stearate), coating agents (ethyl cellulose, ammonium hydroxide, medium-chain triglycerides, oleic acid, sodium alginate, stearic acid)
Your medical provider will help determine the best schedule for you
